Definitely the upside. The 10K could very well com

Definitely the upside. The 10K could very well come out this week. Plus, even though there exists some reimbursement issues, Mr. Schneiderman announced SCRC's plans to acquire equity in two additional compounding pharmacies. This is a brilliant move and I truly believe just the beginning of more similar types of acquisitions. PIMD and the Diabetes Program are flourishing. PIMD alone could outperform compounding. There are plans in the making for implementing a Physician Dispensing Program, this has huge potential. The diversified business model is the basis of SCRC's strong fundamentals. And finally, Mr. Schneiderman hasn't given up on RapiMeds and neither have I. The SCRC train has more than one engine pulling the load.